Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc.> ?p ?o. }
Showing items 1 to 28 of
28
with 100 items per page.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. abstract "Apotex Inc. v. Sanofi‑Synthelabo Canada Inc., [2008] 3 S.C.R. 265, is a leading Supreme Court of Canada decision on the novelty and non-obviousness requirements for a patent in Canada. The Court rejected a challenge by the generic drug manufacturer Apotex to declare Sanofi‑Synthelabo Canada's patent for Plavix, an anti-coagulant drug, invalid. At issue was whether selection patents are invalid in principle, and if they are not, whether the subject selection patent was invalid on the grounds of anticipation, obviousness or double patenting.".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. wikiPageExternalLink summary.html.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. wikiPageExternalLink summary.html.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. wikiPageExternalLink h_wr02152.html.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. wikiPageID "34176378".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. wikiPageRevisionID "599366255".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. caseName "Apotex Inc. v. Sanofi‑Synthelabo Canada Inc.".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. citations "2008".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. decidedDate "2008-11-06".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. docket "31881".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. fullCaseName "Sanofi‑Synthelabo Canada Inc., Sanofi‑Synthelabo and Minister of Health".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. heardDate "2008-04-16".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. history "Judgment against Apotex in the Federal Court of Appeal.".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. notparticipating "McLachlin C.J.".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. ratio "Selection patents are not invalid under the ''Patent Act.".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. ruling "Appeal dismissed".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. scc "2006".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. unanimous "Rothstein J.".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. subject Category:2008_in_Canadian_case_law.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. subject Category:Canadian_patent_case_law.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. subject Category:Supreme_Court_of_Canada_cases.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. comment "Apotex Inc. v. Sanofi‑Synthelabo Canada Inc., [2008] 3 S.C.R. 265, is a leading Supreme Court of Canada decision on the novelty and non-obviousness requirements for a patent in Canada. The Court rejected a challenge by the generic drug manufacturer Apotex to declare Sanofi‑Synthelabo Canada's patent for Plavix, an anti-coagulant drug, invalid.".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. label "Apotex Inc. v. Sanofi-Synthelabo Canada Inc.".
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. sameAs m.0hr4_v8.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. sameAs Q4780733.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. sameAs Q4780733.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. wasDerivedFrom Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc.?oldid=599366255.
- Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc. isPrimaryTopicOf Apotex_Inc._v._Sanofi-Synthelabo_Canada_Inc..